Contract W15QKN21C0014
Regeneron Pharmaceuticals Inc · Department Of Defense · September 14, 2021
Regeneron Pharmaceuticals Inc was awarded a federal contract by Department Of Defense (Department Of The Army) on September 14, 2021 for $2.94 billion of work in biological product (except diagnostic) manufacturing. Performance is in Tarrytown, NY. It was awarded under full and open competition. It uses firm fixed-price contract pricing. If all options are exercised, the contract could reach $5.57 billion.
Contract details
- PIID
- W15QKN21C0014
- Award type
- Definitive Contract
- Pricing
- Firm Fixed Price
- Set-aside
- No Set Aside Used.
- Competition
- Not Competed
- NAICS
- 325414 · Biological Product (Except Diagnostic) Manufacturing
- Product / service
- Drugs And Biologicals
- Place of performance
- Tarrytown, NY
- First action
- September 14, 2021
Description
PRODUCTION OF THERAPEUTIC IN SUPPORT OF NATIONAL EMERGENCY RESPONSE TO CORONAVIRUS 2019 (COVID-19):THE GOVERNMENT IS PURCHASING 2,650,000 DOSES OF THE EMERGENCY USE AUTHORIZATION (EUA) THERAPEUTIC.
Modification timeline
-
September 14, 2021Mod P00005 · Additional Work (New Agreement, Justification Required)$5.57B
Similar contracts
| Recipient | Agency | Date | Obligated |
|---|---|---|---|
| Greer Laboratories, Inc. | Department Of Defense | December 19, 2025 | $470.4K |
| Greer Laboratories, Inc. | Department Of Defense | December 18, 2025 | $0 |
| Lifestream Blood Bank | Department Of Defense | December 18, 2025 | $29.7K |
| Kemp Proteins, Llc | Department Of Defense | December 18, 2025 | $40.0K |
| Applied Dna Sciences, Inc. | Department Of Defense | December 15, 2025 | $1 |
| Sanofi Vaccines Us Inc. | Department Of Defense | December 12, 2025 | $486.7K |
Top contractors in NAICS 325414
Lifetime obligated dollars across all federal contracts in this NAICS code.
| # | Contractor | Contracts | Obligated |
|---|---|---|---|
| 1 | Advanced Technology International | 10 | $225.00M |
| 2 | Sanofi Vaccines Us Inc. | 5 | $27.10M |
| 3 | Meridian Medical Technologies, Llc | 2 | $16.41M |
| 4 | American National Red Cross, The | 12 | $5.59M |
| 5 | Boehringer Ingelheim Animal Health USA Inc | 3 | $3.53M |
| 6 | Versiti Blood Health, Inc. | 12 | $2.52M |
| 7 | American National Red Cross, The | 1 | $1.93M |
| 8 | Miltenyi Biotec, Inc. | 3 | $1.50M |
| 9 | Artemis Technologies Inc | 2 | $983.6K |
| 10 | Oklahoma Blood Institute | 3 | $885.0K |
Track this on BesaGov
Get a free weekly email when this changes — new awards, new sub-awards, new opportunities. No login required.
Continue learning
Keep researching
Frequently asked questions
What is contract W15QKN21C0014?
Contract W15QKN21C0014 is a federal contract awarded to Regeneron Pharmaceuticals Inc by Department Of Defense on September 14, 2021 for $2.94 billion of work classified under BIOLOGICAL PRODUCT (EXCEPT DIAGNOSTIC) MANUFACTURING. It has been modified 0 times since the base award.
Who won contract W15QKN21C0014?
Regeneron Pharmaceuticals Inc won contract W15QKN21C0014 from Department Of Defense.
How much is contract W15QKN21C0014 worth?
Contract W15QKN21C0014 has obligated $2.94 billion to date, with a total potential value of $5.57 billion if all options are exercised.